Serum sCD163 as a potential biomarker for predicting poor functional outcome at 3 months in acute ischemic stroke without reperfusion: a prospective study
Introduction Neuroinflammation plays a critical role in the prognosis of acute ischemic stroke (AIS). Soluble CD163 (sCD163), a marker of monocyte/macrophage activation, has been linked to stroke severity, but its independent prognostic value and clinical utility remain uncertain. This study aimed to evaluate whether s...